Go Back
BIOCRYST PHARMACEUTICALS INC reports $53.33 million Q1 profit
By USInMinutes - May 03, 2023, 01:55 PM ET
Last Updated - Jul 18, 2023, 03:42 PM EDT
The company generated $68.80 million in quarterly revenue
BIOCRYST PHARMACEUTICALS INC [BCRX] has reported fiscal Q1 profit of $53.33 million.
On a per-share basis, the DE based company said its diluted earnings are $0.28.
The Biological Products, Except Diagnostic Substances firm posted revenue of $68.80 million in this period.
Also Read:
- BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update
- BioCryst Presents New Long-term Data Demonstrating Consistently High Attack-free Status Among ...
- BioCryst to Report First Quarter 2023 Financial Results on May 3
- BioCryst Refinances Existing Debt with $450 Million Financing Commitment from Pharmakon
- BioCryst Refinances Existing Debt with $450 Million Financing Commitment from Pharmakon
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News